You are here

The Progress Report Progress never stops. Stay informed with the latest news on breast cancer research, treatment, and prevention.

Tag:

Chemotherapy x

woman wearing face mask consults with her doctor at an appointment

A groundbreaking, BCRF-supported phase III clinical trial, RxPONDER, has just demonstrated that some women with a common type of breast cancer can forgo chemotherapy and be successfully treated with hormone therapy alone.

A study published in the New England Journal of Medicine (NEJM) finds that 99% of women with a low score on the gene test, Oncotype DX®, can forego chemotherapy.

BCRF sat down with Dr. Ian E. Smith to discuss his current work and interest in breast cancer research. Read on to learn more.

 

Large Researcher Headshot - Piccart Martine

BCRF sat down with Dr. Martine Piccart-Gebhart to discuss her current work and interest in breast cancer research. Read on to learn more.

 

Q: Tell us about yourself as a scientist and how you became interested in breast cancer research.